Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study Meeting Abstract


Authors: Diamond, E. L.; Subbiah, V.; Lockhart, C.; Blay, J. Y.; Faris, J. E.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J. S.; Erinjeri, J.; Torrisi, J.; Ulaner, G.; Lacouture, M.; Robson, S.; Makrutzki, M.; Elez, E.; Tabernero, J.; Abdel-Wahab, O.; Baselga, J.; Hyman, D. M.
Abstract Title: Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study
Meeting Title: 58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 128
Issue: 22
Meeting Dates: 2016 Dec 3-6
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-12-02
Language: English
ACCESSION: WOS:000394446804123
PROVIDER: wos
Notes: Meeting Abstract: 480 -- Source: Wos
MSK Authors
  1. Mario E Lacouture
    260 Lacouture
  2. Gary Ulaner
    84 Ulaner
  3. David Hyman
    181 Hyman
  4. Eli Louis Diamond
    83 Diamond
  5. Jose T Baselga
    394 Baselga